Soft palate (dulla) injuries in camels (<i>Camelus dromedarius</i>): clinical, hematobiochemical, histopathological findings and treatment outcomes. [PDF]
Sadan M +4 more
europepmc +1 more source
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan +4 more
wiley +1 more source
Low-Grade Mucoepidermoid Carcinoma Mimicking a Mucocele in the Soft Palate: A Case Report. [PDF]
Baños-Hernández KY +4 more
europepmc +1 more source
Voice and Speech in Atypical Parkinsonian Disorders
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). These impairments are underrecognized and undertreated in neurology clinics.
Federico Rodriguez‐Porcel +48 more
wiley +1 more source
Computational fluid dynamics simulation of upper airway flow and soft tissue deformation in a mouth-breathing patient: a case study. [PDF]
Ji W +6 more
europepmc +1 more source
Epithelioma of the Soft Palate [PDF]
openaire +2 more sources
Longitudinal Videofluorographic Dysphagia Measures in Progressive Supranuclear Palsy
Abstract Background Dysphagia can lead to fatal aspiration pneumonia in progressive supranuclear palsy (PSP). Little is known about the longitudinal progression of dysphagia or whether it differs across PSP clinical variants. Objectives To characterize longitudinal changes in dysphagia across PSP variants and determine relationships with disease ...
Anna Chiara Cattani +8 more
wiley +1 more source
Comprehensive Analysis of the Influence of Soft Palate Inflammation in Brachycephalic Dogs with BOAS III. [PDF]
Kandefer-Gola M +6 more
europepmc +1 more source
Topical Imiquimod for Oral Cavity Leukoplakia and Dysplasia: A Scoping Review
Abstract Objective Imiquimod, a toll‐like receptor 7 agonist, is currently FDA‐approved for treatment of actinic keratoses, superficial BCC, and external genital warts. It has also demonstrated promise in off‐label use in the treatment of oral cavity leukoplakia and dysplasia.
Megan K. Scharner +3 more
wiley +1 more source
Hemiuvulectomy: is it a suitable alternative? [PDF]
Romero-Castro NS +6 more
europepmc +1 more source

